Advanced Search


Study ID Status Title Patient Level Data
111114 Completed A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR DISKUS (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
111116 Completed Prevalence of Chronic Airway Onstruction in a Subject Population with a History of Cigarette Smoking in a Primary care Setting
111117 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group 12-Week Comparison of the Efficacy and Safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler 230/42mcg twice-daily with Fluticasone Propionate/Salmeterol DISKUS 250/50mcg twice-daily in subjects with COPD Study Listed on
111128 Relinquished An open-label, multicentre, randomised phase II study of pazopanib in combination with pemetrexed in first-line treatment of subjects with predominantly non-squamous cell stage IIIB wet/IV non-small cell lung cancer
111149 Completed Evaluate the effect of risk factors that influence the immunogenicity of GSK Biologicals' Twinrix compared to hepatitis A and hepatitis B vaccines given separately and to show the non-inferiority between the vaccines in adults Study Listed on
111155 Completed A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patient suffering from premature ejaculation Study Listed on
111157 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ Infanrix hexa™ vaccine in healthy infants in India Study Listed on
111188 Completed Primary vaccination course in healthy children receiving the pneumococcal vaccine GSK 1024850A co-administered with Tritanrix™-HepB/Hib at 6, 10 and 14 weeks of age Study Listed on
111192 Completed Retrospective Study of Asthma-Related Healthcare Utilization and Costs in Patients with Asthma Receiving Early versus Late Treatment with Fluticasone Propionate/Salmeterol Combination
111194 Completed Advair vs. ICS+Singulair Outcomes Study in Pediatric Patients with Asthma
111198 Completed Use of Beta-blockers and risk of new onset diabetes
111258 Completed Observer-blind, Post-Marketing Study to Compare the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007-2008 Season) Made With New vs. Aged Bulk Material, in Adults Ranging in Age from 18 to 60 Years Study Listed on
111261 Completed Impact of ADA Treatment Guidelines for Type 2 Diabetes on Adherence and Economic Outcomes: Avandia plus Metformin therapy vs. Sulfonylurea plus Metformin therapy among Persistent Patients
111262 Terminated Resource utilization and costs associated with use of rosiglitazone versus insulin as add-on therapy to metformin users in the Veterans Administration
111266 Completed Impact of initiating tiotropium alone versus initiating tiotropium in combination with fluticasone propionate/salmeterol xinafoate combination (FSC) on Chronic Obstructive Pulmonary Disease-related outcomes in patients with pre-existing exacerbations
111295 Completed Immunogenicity and safety study of a GSK influenza vaccine candidate GSK 2115160A in adults. Study Listed on
111314 Completed A First-Time-In-Human, Three-Part, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1521498 in Healthy Subjects Study Listed on
111315 Completed Safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine 257049 when administered on different schedules to infants in Africa Study Listed on
111319 Terminated A Single-Blind, Placebo-Controlled, Randomized First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Dose Escalation of GSK932121 in Healthy Adult Subjects Study Listed on
111341 Completed A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Investigational Study Drug in Healthy Subjects Study Listed on
111344 Completed Immunogenicity and reactogenicity of GSK Biologicals' DTPa-HBV-IPV/Hib vaccine when given as a booster dose Study Listed on
111345 (Mth 12) Completed Long-term follow-up study to assess antibody persistence in children previously vaccinated with four doses of pneumococcal conjugate vaccine in primary vaccination study (105553) and booster vaccination study (107046) Study Listed on
111346 Completed Assessment of long-term antibody persistence and immunological memory in children previously vaccinated with four pneumococcal conjugate vaccine doses and assessment of pneumococcal catch-up vaccination with GSK1024850A at 5 years of age Study Listed on
111347 Completed Study Listed on
111364 Completed A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.